Articles

• Jonas Wiesel 05/23/2013

  Swiss Statup Urturn raises $13.4M - Series A led by Balderton

  

  Urturn which emerged from the company called webdoc has raised $13.4 millions for their series A. The round was led by Balderton for $10.7M and completed by the venture capital arm of the ...

• Source : ? crowdfunding.ch - Online Fundraising 05/21/2013

  INC. Study: Crowdfunders Act Surprisingly Similar to VCs

  Crowdfunding critics take note: A recent study by Wharton professor Ethan Mollick proves that crowdfunders are better than you might think at finding quality entrepreneurs–and even seem to act with less bias than venture ...

• Daniel Bermejo 04/25/2013

  Visionarity. Growing the Team!

  

  When Carl and I started Visionarity about a year ago, we just had on our pockets a big deal of skills, a reasonably large network and our desperate eagerness to transform a great idea into ...

• Daniel Bermejo 04/23/2013

  Visionarity at Google!

  

  With the start of the new year Visionarity installed the first set of Kelvin devices at the Google offices in Zurich. This first pilot is aimed at measuring the amount of energy that is being ...

• Daniel Bermejo 04/23/2013

  Visionarity - Inspiring people to save energy!

  

  Up to 30% of the electricity consumed on the average office is wasted by electrical appliances that are plugged in when they are not in use.This video explains how Kelvin solves this problem by ...

• Jonas Wiesel 03/21/2013

  Microsoft acquires ETH spin-off Netbreeze

  

  Eight years after the purchase of Media-Streams, Microsoft acquires Netbreeze, another Swiss company. This acquisition aims to expend to functionalities of  Microsoft Dynamics CRM.The Microsoft Corporation just recently announced the purchase of the company ...

• Jordi Montserrat 02/12/2013

  Swiss coronary stent developer Qvanteq closes MCHF 4 B round

  

  Financing for the preclinical development has been secured in seed funding in October 2012 from private investors and the Swiss Innovation Promotion AgeThe Swiss coronary stent developer Qvanteq AG  closes series B financing round of ...

• Jordi Montserrat 02/11/2013

  PIQUR secured funding to start the development of innovative anti-cancer therapies

  PIQUR Therapeutics AG  is a targeted cancer therapy start-up company focused on the discovery and the development of innovative anti-cancer drugs. PIQUR was incorporated in August 2011 as a spin-off of the University of Basel ...

• Alexandre Peyraud 01/17/2013

  Spinomix closes a $ 3 Million financing round led by Debiopharm Group

  Lausanne – January 9th, 2013 – Debiopharm Group™ (Debiopharm) and Spinomix SA, a Swiss company advancing molecular diagnostic technologies, announced the closing of a Series A equity investment of $ 3 Million. The financing round was led by ...

• Jordi Montserrat 01/10/2013

  Spinomix closes a $ 3 Million financing round led by Debiopharm Group

  

  Lausanne – January 9th, 2013 – Debiopharm Group     (Debiopharm) and Spinomix    SA, a Swiss company advancing molecular diagnostic technologies, announced the closing of a Series A equity investment of $ 3 Million. The financing round was led by ...

Photos

No photos in this group.

Videos

• 

  Watalys - producing your own powerful disinfectant - water and premises

  Bulane
  • Comments